Another hypothetical strategy, inspired by the fight against HIV, is a ‘treat‐all’ approach, where antiviral treatment could be offered to all individuals tested positive for HBsAg, irrespective of their ALT levels, viral loads, or degree of liver fibrosis. This evidence concerns the gene GPT and Hepatic fibrosis.